Adenoid Cystic Carcinoma of the Head and Neck
📧 Sign up to get email alerts when something new happens for Adenoid Cystic Carcinoma of the Head and Neck.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: A Multi-omics Approach to Disclose Progression and Underlying Biology of Head and Neck Adenoid Cystic Carcinoma
A clinical trial is recruiting to apply multi-omics analysis to understand progression and biology of head and neck adenoid cystic carcinoma…
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: Study of OBT076 Associated or Not in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck [Phase 1]
A Phase 1 clinical trial of OBT076 in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck has been terminate…
-
CLINICAL_TRIALS trial_result · 2021-08-19Clinical Trial Update: Chidamide Combined With Cisplatin in Head and Neck Adenoid Cystic Carcinoma (HNACC) [Phase 2]
Phase 2 clinical trial of chidamide in combination with cisplatin for head and neck adenoid cystic carcinoma has been completed.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: All-trans Retinoic Acid (ATRA) in the Treatment of Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck [Phase 2]
Phase 2 clinical trial evaluating all-trans retinoic acid (ATRA) for recurrent/metastatic adenoid cystic carcinoma of the head and neck.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and Neck [Phase 2]
This document notes a Phase 2 trial of gemcitabine for recurrent or metastatic adenoid cystic carcinoma of the head and neck, with the study…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2007-09-26Clinical Trial Update: Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck [Phase 2]
Phase 2 clinical trial evaluating imatinib (Glivec) in patients with adenoid cystic carcinoma of the head and neck; current status is unknow…